The immune system can either combat cancer by immunosurveillance where the cancer is recognized and cross-presented by APCs (43) or promote tumor progression via (in)direct suppression of CD8+ T lymphocytes and other immune cells (43, 44). This evidence concerns the gene CD8A and neoplasm.